Xenon Pharmaceuticals Inc

XENENASDAQ • USD
40.04 USD
↘ 0.44 (1.09%)🟢LIVE (AS OF 09:57 AM EST)
🟢Market: OPEN

Xenon Pharmaceuticals Inc (XENE) is currently trading at $40.04. Our models show a "Neutral" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$40.32
High?$41.61
Low?$38.01
Prev. Close?$40.48
Volume?29.4K
Avg. Volume?1.4M
VWAP?$40.36
Rel. Volume?0.02x
Bid / Ask
Bid?$34.03 × 100
Ask?$40.64 × 100
Spread?$6.61
Midpoint?$37.34
Valuation & Ratios
Market Cap?4.0B
Shares Out?96.7M
Float?90.8M
Float %?93.9%
P/E Ratio?N/A
P/B Ratio?3.47
EPS?-$4.36
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
4.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
34
Piotroski F-Score?0/9Weak
Altman Z-Score?42.43Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.11%Elevated
Short Interest?7.4M
Days to Cover?6.4
Free Float90.8M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?21.19Strong
Quick Ratio?21.19Strong
Cash Ratio?1.82Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
49
3.47FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-37.4%WEAK▾
ROA?
S&P
3
-35.7%WEAK▾
Cash Flow & Enterprise
FCF?$-357108000
Enterprise Value?$3.9B
Fundamentals ratios updated end of day